| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.80B | 47.06B | 43.24B | 37.84B | 33.32B | 28.84B |
| Gross Profit | 16.29B | 15.54B | 14.46B | 12.83B | 11.89B | 10.22B |
| EBITDA | 11.03B | 10.24B | 10.18B | 9.27B | 8.75B | 7.17B |
| Net Income | 6.10B | 5.81B | 5.97B | 5.42B | 4.93B | 3.59B |
Balance Sheet | ||||||
| Total Assets | 107.53B | 116.31B | 112.79B | 100.31B | 97.65B | 109.79B |
| Cash, Cash Equivalents and Short-Term Investments | 7.03B | 10.39B | 7.92B | 6.68B | 6.21B | 7.30B |
| Total Debt | 42.56B | 43.98B | 44.48B | 45.56B | 46.62B | 59.96B |
| Total Liabilities | 59.27B | 70.70B | 69.68B | 59.69B | 60.03B | 74.95B |
| Stockholders Equity | 48.08B | 45.62B | 43.11B | 40.54B | 37.56B | 34.79B |
Cash Flow | ||||||
| Free Cash Flow | 11.27B | 10.05B | 10.40B | 9.18B | 6.91B | 8.98B |
| Operating Cash Flow | 12.63B | 11.23B | 11.44B | 10.26B | 8.15B | 10.36B |
| Investing Cash Flow | -6.50B | 642.00M | -1.96B | -1.58B | 9.71B | -11.56B |
| Financing Cash Flow | -9.29B | -9.51B | -8.24B | -8.25B | -18.98B | 1.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥131.46B | 14.74 | ― | 2.09% | 5.78% | 10.26% | |
72 Outperform | ¥331.86B | 22.28 | 9.66% | 0.55% | 14.33% | 36.83% | |
70 Outperform | ¥132.28B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
63 Neutral | ¥138.01B | 22.64 | ― | 1.88% | 16.70% | -0.37% | |
63 Neutral | ¥777.15B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥67.51B | 17.62 | ― | 1.95% | 23.52% | -13.42% |